Douglas Allington
Impact in
-
- Multiple Sclerosis Research Studies
- Vitamin D Research Studies
Papers in
-
- Multiple Sclerosis Research Studies 4
-
- Antibiotics Pharmacokinetics and Efficacy 2
- Co-authors
- Michael P. Rivey (7 shared papers)Curtis W. Noonan (1 shared paper)J. D. Stone (1 shared paper)Timothy P. Stratton (1 shared paper)Mary H.H. Chandler (2 shared papers)Michael R. Harrison (1 shared paper)Thomas S. Foster (1 shared paper)Arthur Mazzu (1 shared paper)
- Journals
- Annals of Pharmacotherapy (4 papers)American Journal of Health-System Pharmacy (2 papers)The Journal of Clinical Pharmacology (1 paper)Clinical Therapeutics (1 paper)Drug Design Development and Therapy (1 paper)
- Partner nations
- United States
In The Last Decade
Douglas Allington
13 papers receiving 381 citations
Peers
Comparison fields: 5 of 106
- Applied Microbiology and Biotechnology 12
- Pathology and Forensic Medicine 81
- Emergency Medical Services 30
- Molecular Medicine 16
- Infectious Diseases 50
Countries citing papers authored by Douglas Allington
This map shows the geographic impact of Douglas Allington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Allington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Allington more than expected).
Fields of papers citing papers by Douglas Allington
This network shows the impact of papers produced by Douglas Allington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Allington. The network helps show where Douglas Allington may publish in the future.
Co-authors
The 10 scholars most cited alongside Douglas Allington, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 85 | |
| 2 | 2001 | 84 | |
| 3 | 2010 | 60 | |
| 4 | 2008 | 38 | |
| 5 | 2013 | 32 | |
| 6 | 2011 | 27 | |
| 7 | 2005 | 18 | |
| 8 | 1997 | 15 | |
| 9 | 1995 | 15 | |
| 10 | 1992 | 10 | |
| 11 | 2012 | 6 | |
| 12 | 1995 | 5 | |
| 13 | 1991 | 4 |
About Douglas Allington
Douglas Allington is a scholar working on Pathology and Forensic Medicine, Pharmacology, Cardiology and Cardiovascular Medicine, Psychiatry and Mental health and Infectious Diseases, having authored 13 papers that have together received 399 indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (4 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Epilepsy research and treatment (2 papers), Antimicrobial Resistance in Staphylococcus (2 papers), Polyomavirus and related diseases (2 papers), Pharmaceutical Practices and Patient Outcomes (1 paper), Analytical Methods in Pharmaceuticals (1 paper) and Trauma and Emergency Care Studies (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (12 citations), Pathology and Forensic Medicine (81 citations), Emergency Medical Services (30 citations), Molecular Medicine (16 citations) and Infectious Diseases (50 citations). Douglas Allington has collaborated with scholars based in United States. Frequent co-authors include Michael P. Rivey, Curtis W. Noonan, J. D. Stone, Timothy P. Stratton, Mary H.H. Chandler, Michael R. Harrison, Thomas S. Foster, Arthur Mazzu, John Lettieri and G. Dennis Clifton. Their work appears in journals such as Annals of Pharmacotherapy, American Journal of Health-System Pharmacy, The Journal of Clinical Pharmacology, Clinical Therapeutics and Drug Design Development and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.